{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:19:20Z","timestamp":1791317960873,"version":"4.3.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DK49302"],"award-info":[{"award-number":["R01 DK49302"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K23 HL136262"],"award-info":[{"award-number":["K23 HL136262"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL151293"],"award-info":[{"award-number":["R01 HL151293"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K24 HL103845"],"award-info":[{"award-number":["K24 HL103845"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 DK040561"],"award-info":[{"award-number":["P30 DK040561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Increased renin angiotensin aldosterone system (RAAS) activity may contribute to excess cardiovascular disease in people with HIV (PWH). We investigated how RAAS blockade may improve myocardial perfusion, injury, and function among well-treated PWH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Forty PWH, on stable ART, without known heart disease were randomized to eplerenone 50 mg PO BID (n = 20) or identical placebo (n = 20) for 12 months. The primary endpoints were (1) myocardial perfusion assessed by coronary flow reserve (CFR) on cardiac PET or stress myocardial blood flow (sMBF) on cardiac MRI or (2) myocardial inflammation by extracellular mass index (ECMi) on cardiac MRI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Beneficial effects on myocardial perfusion were seen for sMBF by cardiac MRI (mean [SD]: 0.09 [0.56] vs \u22120.53 [0.68] mL\/min\/g; P = .03) but not CFR by cardiac PET (0.01 [0.64] vs \u22120.07 [0.48]; P = .72, eplerenone vs placebo). Eplerenone improved parameters of myocardial function on cardiac MRI including left ventricular end diastolic volume (\u221213 [28] vs 10 [26] mL; P = .03) and global circumferential strain (GCS; median [interquartile range 25th\u201375th]: \u22121.3% [\u22122.9%\u20131.0%] vs 2.3% [\u22120.4%\u20134.1%]; P = .03), eplerenone versus placebo respectively. On cardiac MRI, improvement in sMBF related to improvement in global circumferential strain (\u03c1 = \u22120.65, P = .057) among those treated with eplerenone. Selecting for those with impaired myocardial perfusion (CFR &amp;lt;2.5 and\/or sMBF &amp;lt;1.8), there was a treatment effect of eplerenone versus placebo to improve CFR (0.28 [0.27] vs \u22120.05 [0.36]; P = .04). Eplerenone prevented a small increase in troponin (0.00 [\u22120.13\u20130.00] vs 0.00 [0.00\u20130.74] ng\/L; P = .03) without effects on ECMi (0.9 [\u22122.3\u20134.3] vs \u22120.7 [\u22122.2\u2013\u22120.1] g\/m2; P = .38). CD4+ T-cell count (127 [\u221238\u2013286] vs \u22126 [\u2212168\u201353] cells\/\u03bcL; P = .02) increased in the eplerenone- versus placebo-treated groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>RAAS blockade with eplerenone benefitted key indices and prevented worsening of myocardial perfusion, injury, and function among PWH with subclinical cardiac disease when compared with placebo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration<\/jats:title>\n                  <jats:p>NCT02740179 (https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02740179?term=NCT02740179&amp;draw=2&amp;rank=1).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciad310","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T15:49:42Z","timestamp":1685029782000},"page":"1166-1175","source":"Crossref","is-referenced-by-count":15,"title":["Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)\u2014Results From the MIRACLE HIV Study"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-4770","authenticated-orcid":false,"given":"Suman","family":"Srinivasa","sequence":"first","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allie R","family":"Walpert","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teressa S","family":"Thomas","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Huck","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jerosch-Herold","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeeh","family":"Islam","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Lu","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia H","family":"Burdo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Lewis Katz School of Medicine at Temple University , Philadelphia, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R","family":"deFilippi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, INOVA Heart and Vascular Institute , Falls Church, Virginia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn N","family":"Dunderdale","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Feldpausch","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjna","family":"Iyengar","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Shen","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Baak","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Lewis Katz School of Medicine at Temple University , Philadelphia, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Torriani","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal Imaging and Intervention, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory K","family":"Robbins","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-0759","authenticated-orcid":false,"given":"Raymond","family":"Kwong","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"DiCarli","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail K","family":"Adler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K","family":"Grinspoon","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"key":"2024021012505034800_ciad310-B1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"2024021012505034800_ciad310-B2","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"2024021012505034800_ciad310-B3","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy","year":"2012","journal-title":"Circulation"},{"key":"2024021012505034800_ciad310-B4","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"key":"2024021012505034800_ciad310-B5","first-page":"1282","article-title":"The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping","volume":"141","author":"Knott","year":"2020","journal-title":"Circulation"},{"key":"2024021012505034800_ciad310-B6","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1210\/jc.2015-1461","article-title":"RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients","volume":"100","author":"Srinivasa","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021012505034800_ciad310-B7","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/infdis\/jiw392","article-title":"Effects of sodium restriction on activation of the renin-angiotensin-aldosterone system and immune indices during HIV infection","volume":"214","author":"Srinivasa","year":"2016","journal-title":"J Infect Dis"},{"key":"2024021012505034800_ciad310-B8","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/jc.2017-02198","article-title":"Excessive adiposity and metabolic dysfunction relate to reduced natriuretic peptide during RAAS activation in HIV","volume":"103","author":"Murphy","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021012505034800_ciad310-B9","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2018-00330","article-title":"Randomized, placebo-controlled trial to evaluate effects of eplerenone on metabolic and inflammatory indices in HIV","volume":"103","author":"Srinivasa","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021012505034800_ciad310-B10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/db14-0670","article-title":"Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes","volume":"64","author":"Garg","year":"2015","journal-title":"Diabetes"},{"key":"2024021012505034800_ciad310-B11","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.117.029992","article-title":"Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease","volume":"136","author":"Gupta","year":"2017","journal-title":"Circulation"},{"key":"2024021012505034800_ciad310-B12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"2024021012505034800_ciad310-B13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/HCO.0b013e328312c2f5","article-title":"Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease","volume":"23","author":"Jerosch-Herold","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"2024021012505034800_ciad310-B14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12968-017-0388-9","article-title":"Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography","volume":"19","author":"Engblom","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024021012505034800_ciad310-B15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11886-014-0483-6","article-title":"Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography","volume":"16","author":"Waller","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"2024021012505034800_ciad310-B16","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s00259-019-04641-9","article-title":"Comparison between quantitative cardiac magnetic resonance perfusion imaging and [(15)O]H(2)O positron emission tomography","volume":"47","author":"Everaars","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024021012505034800_ciad310-B17","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1161\/01.CIR.96.10.3369","article-title":"Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE study (Doppler Endpoints Balloon Angioplasty Trial Europe)","volume":"96","author":"Serruys","year":"1997","journal-title":"Circulation"},{"key":"2024021012505034800_ciad310-B18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2024021012505034800_ciad310-B19","doi-asserted-by":"crossref","first-page":"e004091","DOI":"10.1161\/CIRCIMAGING.115.004091","article-title":"Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients","volume":"9","author":"Luetkens","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2024021012505034800_ciad310-B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.03.019","article-title":"The effect of sacubitril\/valsartan on left ventricular myocardial deformation in heart failure with preserved ejection fraction (PARAMOUNT trial)","author":"Biering-Sorensen","year":"2023","journal-title":"J Card Fail."},{"key":"2024021012505034800_ciad310-B21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jchf.2021.02.016","article-title":"Mineralocorticoid receptor antagonist improves cardiac structure in type 2 diabetes: data from the MIRAD trial","volume":"9","author":"Brandt-Jacobsen","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2024021012505034800_ciad310-B22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2014.04.005","article-title":"Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease","volume":"91","author":"Bene","year":"2014","journal-title":"Steroids"},{"key":"2024021012505034800_ciad310-B23","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1128\/JVI.01722-16","article-title":"Specific inhibition of HIV infection by the action of spironolactone in T cells","volume":"90","author":"Lacombe","year":"2016","journal-title":"J Virol"},{"key":"2024021012505034800_ciad310-B24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fphys.2018.00899","article-title":"Eplerenone reverses cardiac fibrosis via the suppression of Tregs by inhibition of kv1.3 channel","volume":"9","author":"Shao","year":"2018","journal-title":"Front Physiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad310\/50722334\/ciad310.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/8\/1166\/56655490\/ciad310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/8\/1166\/56655490\/ciad310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T12:51:28Z","timestamp":1707569488000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/8\/1166\/7181032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,5,27]]},"published-print":{"date-parts":[[2023,10,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad310","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,15]]},"published":{"date-parts":[[2023,5,27]]}}}